Overview

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Comparative Pharmacokinetics of Asasantin Extended Release (ER) and of immediate release Persantin tablets combined with Acetyl salicylic acid (ASA) tablets
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Aspirin
Aspirin, Dipyridamole Drug Combination
Dipyridamole
Salicylates
Salicylic Acid